Blog | Help 4 HD International

top of page

HELP 4 HD INTERNATIONAL

New Resource Database is Live 🎉 Click Here

The Huntington's Post

Search

Katie Jackson, CEO of Help 4 HD, initial response to the uniQure News

Katie Jackson, CEO of Help 4 HD, initial response to the uniQure News

Katie Jackson, CEO of Help 4 HD, initial response to the uniQure News

Katie Jackson, CEO of Help 4 HD, was asked her initial response to the news today. We wanted to share that response with our community....

katie8288

30 minutes ago3 min read

Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets

Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets

Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets

katie8288

Apr 280 min read

Understanding Chorea vs. Akathisia: Insights from Expert Discussion

Understanding Chorea vs. Akathisia: Insights from Expert Discussion

Understanding Chorea vs. Akathisia: Insights from Expert Discussion

Recently, during a HIPE discussion the conversation shed light on the complexities of managing chorea, a involuntary movement frequently...

katie8288

Apr 202 min read

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease

LEXINGTON, Mass. and AMSTERDAM, April 17, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing...

katie8288

Apr 174 min read

Blog: Blog2

bottom of page